Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over [ID5104]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 29 May 2024
DCVax-L for treating glioblastoma [ID836]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Asunercept for treating glioblastoma [1301]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Vocimagene amiretrorepvec with extended-release 5-fluorocytosine for treating recurrent high-grade glioma [ID1425]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
MTX110 for untreated diffuse intrinsic pontine glioma [ID2695]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC